CVE-2025-55888: Cross-site Scripting
Source CVE Database V5
Not known to be exploited · CVSS 7.3 High.
Data as of 26 Oct 2026, 12:55 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 37% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:LExploitation evidence
Disclosed: evidence found.
CVE published 22 Sep 2025
Detectable: no evidence on record.
No public nuclei template indexed
Weaponised: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 26 Oct 2026.
What to do
AI-suggested
Until an official fix is available, users should consider mitigating risks by restricting access to the affected Ajax endpoint or employing web application firewalls that can detect and block XSS payloads. Avoid exposing sensitive data in the accountName field if possible. Monitor vendor communications for updates on patches or official mitigations.
Description
Cross-Site Scripting (XSS) vulnerability was discovered in the Ajax transaction manager endpoint of ARD. An attacker can intercept the Ajax response and inject malicious JavaScript into the accountName field. This input is not properly sanitized or encoded when rendered, allowing script execution in the context of users browsers. This flaw could lead to session hijacking, cookie theft, and other malicious actions.